Trelagliptin succinate A tert-Butyl ester 11(4):497-505
Pay in 4 interest-free payments of $9.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 23 - Nov 28
Live Spec
Trelagliptin succinate A tert-Butyl ester 11(4):497-505Trelagliptin, also known as SYR 472, is a long acting dipeptidyl peptidase 4 (DPP 4) inhibitor that is being developed by Takeda for the treatment of type 2 diabetes (T2D). Once weekly SYR 472 treatment produced clinically and statistically significant improvements in glycaemic control in patients with type 2 diabetes. It was well tolerated and might be a new treatment option for patients with this disease. Trelagliptin (Zafatek()) was approved in
Store: ecoilumi.com.br · Domain: ecoilumi.com.br

























